Close

Notable Analyst Rating Changes 11/29: (LCC) (RIMM) (DNR) Upgraded; (PPL) (NBR) (ZION) Downgraded Nov 29, 2011 11:18AM
Barclays on U.S. Health Care Distribution & Technology: Branded Drug Price Survey - October Nov 15, 2011 02:32PM
Barclays maintains an 'Overweight' on Merck (MRK); R&D Briefing: Positive Surprises - Dividend Increase; Progress on HCV & Alzheimer's Nov 11, 2011 02:19PM
Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); Outlook Depends on Continuity of Counter-cyclicals and Solanezumab Oct 21, 2011 02:55PM
Barclays on U.S. Major Pharmaceuticals: Q3 Preview: BMY and PFE to Stand Apart From the Defensive Play Story Oct 13, 2011 02:32PM


Sep 14, 2011 12:45PM UPDATE - Barclays Downgraded Pfizer (PFE) to Equalweight; Inferior Revenue Recovery Post 'Patent Cliff' Through 2020
Jun 10, 2011 03:21PM Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
May 24, 2011 01:31PM Barclays Maintains an 'Overweight' on Merck (MRK) - Model Update
May 16, 2011 01:53PM Barclays Maintains an 'Overweight' on Merck (MRK); Victrelis Victorious with Strong Label
Mar 23, 2011 12:45PM Barclays Maintains an 'Overweight' on Merck (MRK); Model Update: Termination of Animal Health JV
Jan 24, 2011 02:50PM Barclays on U.S. Major Pharmaceuticals: U.S. Major Pharma 2011 Outlook: A View Beyond the Cliff
Nov 18, 2010 02:43PM Barclays Maintains an 'Overweight' on Merck (MRK); Anacetrapib: DEFINing Safety, Outcome Benefit to be REVEALed
Oct 14, 2010 04:22PM U.S. Major Pharmaceuticals: Q3 Preview: A hit but not a home run
Jan 13, 2010 11:39AM Notable Analyst Rating Changes 1/13: BIDU, WYN, HMA, IACI, MRK Upgraded; ZEUS, AFFX, GSK, PCU Downgraded
Nov 12, 2009 10:59AM Notable Analyst Rating Changes: ARO, CSX, PFWD, SIRI Upgraded; BRCD, BNI Downgraded
Apr 9, 2009 09:45AM Morning Movers 4/9: TXT, WFC, APWR, CRME, USB, EXM, BAC, GYMB, CSH Higher; MOV, ELMG, ANF Lower
Mar 13, 2009 10:16AM David Moenning's Daily State of the Markets: 3/13
Feb 3, 2009 10:32AM David Moenning's Daily State of the Markets: 2/3
Jan 23, 2009 09:58AM Notable Analyst Rating Changes 1/23: MRK, BBT, SIAL, JCG Upgraded; CME, PBR, AMD, MSCC Downgraded
Dec 4, 2008 10:01AM Morning Movers 12/04: Merck (MRK) Lower On Guidance, Amazon.com (AMZN) Higher On Upgrade